Galanin analogs prevent mortality from seizure-induced respiratory arrest in mice.
Journal Information
Full Title: Front Neural Circuits
Abbreviation: Front Neural Circuits
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Conflict of interest CM was a former full-time employee of NeuroAdjuvants, Inc., a biotechnology company seeking to develop galanin-based neuropeptides for CNS conditions. CM holds two patents for galanin-based therapies for CNS conditions (University of Utah). The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."
Funding Disclosure
Evidence found in paper:
"Funding This studies were funded by the ALSAM Foundation."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025